Quinlan Paul T sold ORKA
March 16, 2026 · Form 4 insider transaction
Quinlan Paul T sold 733 shares of Oruka Therapeutics, Inc. at $41.30 per share, a transaction worth $30.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
733
Price
$41.30
Total value
$30.3K
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after31,767
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.